Le Lézard
Classified in: Health
Subjects: MAV, FVT, MAT

MEDIA ADVISORY - Cannabis industry insiders available to comment on state of legalization in Canada this 4/20


Hill+Knowlton's cannabis experts will be available for comment on 4/20 - April 18th, 19th and 20th, 2018.

TORONTO, April 18, 2018 /CNW/ - It is an exciting and challenging time as Canada approaches the legalization of recreational cannabis. As 4/20 is upon us, there is still uncertainty caused by the debate of Bill C-45, The Cannabis Act, in federal Parliament. This is occurring while the provinces are deciding and implementing their respective method of cannabis distribution. Moreover, there is also the complex regulatory environment around the marketing of cannabis to consumers.

Experts from Hill+Knowlton will be available to discuss the following:

Who:

About Hill+Knowlton's cannabis practice

H+K has a team of experts that have been advising clients in the medical cannabis space since 2013. We assist clients in navigating the regulatory and application process, support their communications and marketing efforts and provide public affairs support which allows our clients to achieve success today, while preparing for the future of this fast-changing industry.

SOURCE Hill & Knowlton Canada


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: